Postmarketing commitment safety study of HZ/su to evaluate pregnancy exposures and outcomes in immunodeficient or immunosuppressed women between 18 and 49 years of age (EPI-ZOSTER-039 VS US DB 214420) First published 31/03/2023 Last updated 05/09/2025 EU PAS number:EUPAS104070 Study Ongoing